Clinical Emergency Value Of 45mm Vascular Access Needles For Obese Patients

Jul 25, 2026

 

With the continuous increase of obese patient groups in global clinical treatment, the difficulty of emergency vascular access establishment has become a key pain point restricting the improvement of emergency rescue success rate. Obese patients have thick subcutaneous fat, blurred bony landmarks, and deep bone cortex position, making conventional venous puncture and standard 25 mm intraosseous vascular access needles difficult to work effectively. Professional vascular access needle manufacturers aim at the emergency treatment characteristics of obese patients, and the independently developed 45 mm vascular access needle has become the core special emergency device for obese critically ill patients, filling the industry gap of targeted puncture instruments for obese patients.

In conventional emergency treatment, medical staff often choose 25 mm vascular access needles for intraosseous puncture according to operational inertia, but this specification has obvious limitations in obese patient scenarios. The effective penetration length of the 25 mm needle is insufficient to cross the thick subcutaneous soft tissue of obese patients and reach the bone marrow cavity. The needle tip often stays in the soft tissue layer, failing to establish effective central circulation access, resulting in inability to infuse emergency drugs and liquids normally. Repeated puncture not only delays the rescue time, but also increases the risk of local tissue damage, hematoma and infection, bringing additional pain and safety hazards to obese critically ill patients.

The 45 mm vascular access needle launched by professional manufacturers completely solves the above clinical problems. The extended needle body design provides sufficient penetration depth reserve, which can easily cross the thick fat layer of obese patients and accurately pierce the bone cortex to form a stable intraosseous infusion channel. Clinical practice verification shows that the 45 mm needle has ultra-high adaptability in obese patient treatment, and its biggest operational advantage is depth-free universal adaptation. Clinicians do not need to measure subcutaneous fat thickness in advance or adjust the puncture depth dynamically. By following the standard operation of piercing the bone cortex and avoiding burying the needle, stable vascular access can be successfully established at one time.

The three common clinical intraosseous puncture sites (tibia, humerus, sternum) are all applicable to 45 mm vascular access needles. For obese patients with severe fat accumulation and unable to palpate tibial trochanter landmarks accurately, the 45 mm long needle can effectively avoid positioning errors and insufficient puncture depth caused by unclear landmarks. Even if part of the needle body is exposed outside the skin after puncture, it will not affect the stability of the channel and the safety of infusion, nor will it cause tissue compression or secondary damage. This flexible and safe design fully considers the complex physical characteristics of obese patients and the uncertainty of on-site emergency operations.

All 45 mm vascular access needles produced by formal manufacturers adopt medical stainless steel material, which has excellent biocompatibility, corrosion resistance and structural stability. The precision cutting needle tip ensures smooth and low-resistance puncture, avoids violent operation, and enables medical staff to fully control the operation process. As a special emergency device for obese patients, 45 mm vascular access needles have become essential reserve supplies for major hospital emergency departments, ICU and pre-hospital emergency teams. Manufacturers continue to optimize product structure and process parameters according to clinical feedback, further improve the puncture success rate and safety, and provide reliable device support for the emergency treatment of obese critically ill patients worldwide.